Register | Forgot password?
Switch to Arabic
Friday, November 27 - 2009
Page navigation Browse related articles

Dr. B.R. Shetty conferred the Mohammed Bin Rashid Al Maktoum Business Award

  • United Arab Emirates: Wednesday, February 28 - 2007 at 10:10
  • PRESS RELEASE

Dr. B.R. Shetty, the Managing Director & CEO of Neopharma and NMC Group, has been awarded the prestigious Mohammed Bin Rashid Al Maktoum Business Award.

Article continues below
  • H.H. Sheikh Mohammed Bin Rashid Al Maktoum, Vice-President and Prime Minister of the UAE, Ruler of Dubai, presenting the award to Dr. B.R. Shetty, Managing Director & CEO - Neopharma and NMC Group.
    H.H. Sheikh Mohammed Bin Rashid Al Maktoum, Vice-President and Prime Minister of the UAE, Ruler of Dubai, presenting the award to Dr. B.R. Shetty, Managing Director & CEO - Neopharma and NMC Group.
The award was presented by His Highness Sheikh Mohammad Bin Rashid Al Maktoum, Vice-President and Prime Minister of the UAE, Ruler of Dubai at a glittering ceremony. It recognises the pioneering initiatives of Neopharma, the Pharmaceutical Manufacturing arm of NMC Group.

Based on Business High Performance Model (BHP Model), the award evaluates and recognizes the performance of companies from both management and performance criteria. A company's strategic initiative, leadership perspectives, quality imperatives, corporate culture, corporate social responsibility, performance output, outcome and impact are appraised. The occasion brought dual recognition to Dr. Shetty in the form of a second award for NMC Trading - the Re-Export division of NMC Group.

Expressing his joy on being conferred the honour, Dr. B.R. Shetty said,

"This award will encourage me to innovate and further the goal of bringing the world's best pharmaceutical and healthcare facilities to the GCC and the UAE in particular. It is truly invigorating to receive this honour that gives me a sense of fulfilment."


Within a span of three years, Neopharma has developed more than 62 formulations. Time and again the firm has demonstrated its competitive advantage of introducing new products in quick succession and emerged as a leading pharmaceutical manufacturer with innovative and generic products. It also has key expansion plans in line with major forays into Biotechnology and Nanotechnology.

Neopharma's Dr. B.R. Shetty's Research Centre recently entered into a joint venture with leading biotechnology major, Biocon. This landmark agreement between the two companies heralded the region's first facility to develop life saving biotech and biopharmaceutical products. Dr. Shetty stated that Neopharma's foray into Biotech will influence a "fresh wave of new manufacturing technology". The company also has plans for backward integration with the production of patent products like Oral Insulin, Anti-obesity, Cardiac, Anti-cancer and Oncology products, which will be on par with the best multi-national standards. Neopharma is the first pharmaceutical company in the industrial category to receive the 'Best Manufacturer' award.

Dr. B.R. Shetty started his journey way back in 1973 and is today considered the pioneer in healthcare and the first to offer comprehensive medical services under a single roof. Numerous awards and accolades have been presented to him in recognition of his accomplishments and exemplary acts towards the development of the community. These include the Order of Abu Dhabi, which has been given in the memory of late Shaikh Zayed under the guidance and auspices of H. H. Sheikh Mohammed bin Zayed Al Nahyan, the Crown Prince of Abu Dhabi.

In conclusion, Dr. Shetty stated, "31 years of hard-work has been brought to fore with this award and I aim to work harder towards realising the vision of late His Highness Sheikh Zayed Bin Sultan Al Nahyan to provide quality healthcare for all."
Also consider reading:
Page navigation Browse related articles
Log in to request more information from NMC Group

Disclaimer:

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions